DUBLIN--(BUSINESS WIRE)--The "Global Pediatric Interventional Cardiology Market - Segmented by Product and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.
The Pediatric Interventional Cardiology Market is expected to grow at a CAGR of 6.5%.
During the last 10 years, there have been various technological advancements in the pediatric interventional cardiology market. Some of the new advancements in cardiac imaging modalities, such as intracardiac echocardiography (ICE), real-time 3-dimensional (3D), transesophageal echocardiography (TEE), cardiac computed tomography (CT), magnetic resonance imaging (MRI), holography, 3D printing, etc. These technological advances can treat congenital heart diseases.
Therapies like percutaneous pulmonic valve implantation, have achieved success in the market. The recent advancement of percutaneous pulmonary valve implantations, has helped reduce the risk and stress of open-heart surgery. Hence, due to these continuous technological advances, the market is growing at a faster pace.
Other factors driving the market include increasing awareness among the population, increased preference of minimally invasive procedures over conventional surgeries, and the rising number of the congenital disorders.
The US pediatric interventional cardiology market has the largest share among the North American countries, which can be due to the rising number of the congenital heart defects. The Asia-Pacific region is also projected to grow at a significant rate during the next 7 years, due to the growing government investments in cardiology and medical tourism.
Key Developments in the Market
- March 2017: Boston Scientific announced that it had signed a definitive agreement to obtain Symetis SA, a manufacturer of transcatheter aortic valve replacement systems.
Key Topics Covered
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.2 Market Restraints
6.4 Key Challenges
7. Market Segmentation
7.1 By Product
7.2 By Geography
8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.2 Boston Scientific Corporation
9.3 Cardinal Health
9.4 Edwards Lifesciences Corporation
9.5 GE Healthcare
9.6 Gore Medical
9.8 NuMED Inc.
9.9 Siemens Healthcare
9.10 List Not Exhaustive
10. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/vjzzhs/pediatric?w=4